Key facts
- Notable investors include Zhong He Yuan Liang.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Shanxi Heyang Pharmaceutical
- ·The full record, as it builds
Funding rounds
No funding rounds for Shanxi Heyang Pharmaceutical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Shanxi Heyang Pharmaceutical
Developer of pharmaceutical products designed to improve health and wellness. The company offers innovative drug formulations and advanced manufacturing techniques, enabling healthcare providers to deliver effective treatments and enhance patient outcomes.
- Sector
- Healthcare
- HQ
- Datong, China
- Founded
- 2023
- Ownership
- Privately Held (backing)
Shanxi Heyang Pharmaceutical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Shanxi Heyang Pharmaceutical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Shanxi Heyang Pharmaceutical in its N-PORT filings yet. We sweep new filings monthly.